Salix Pharmaceuticals, Inc., et al., v. Novel Laboratories, Inc.C.A. No. 14-213 - GMS, July 10, 2015

Sleet, J. The court construes three terms from the four patents-in suit.

The following terms were considered:

  1. Core
  2. Without food
  3. Remission

The court finds that the patentee expressly surrendered the full scope of the term “core” during prosecution.